TP53 and cancer: These comprise minuscule molecule medications that can rejuvenate or stabilize the p53 protein, gene manipulation methodologies that introduce operative copies of the TP53 gene into neoplastic cells, and immunotherapeutic manoeuvres that utilize the immune system to attack cancer cells bearing TP53 gene aberrations.